Cellular Logistics Revenue and Competitors
Estimated Revenue & Valuation
- Cellular Logistics's estimated annual revenue is currently $1.6M per year.
- Cellular Logistics's estimated revenue per employee is $155,000
Employee Data
- Cellular Logistics has 10 Employees.
- Cellular Logistics grew their employee count by 0% last year.
Cellular Logistics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP and Chief Scientific Officer | Reveal Email/Phone |
2 | Lead Development Scientist | Reveal Email/Phone |
3 | Lead Development Scientist | Reveal Email/Phone |
Cellular Logistics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Cellular Logistics?
Cellular Logistics, Inc. (CL) is a U.S. life sciences company that is dedicated to improving the lives of individuals who suffer from heart failure. CL was founded in 2016 by a multi-disciplinary team of physicians, scientists and business entrepreneurs at the University of Wisconsin-Madison. Our vision is to advance myocardial reparative and regenerative therapies that are poised to treat patients with heart failure. Our product, Tandemâ„¢ HF, promises to revitalize damaged heart tissue and improve outcomes for the estimated 30 million patients worldwide projected to suffer from heart failure by 2030.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | -17% | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $0.9M | 10 | 0% | N/A |
#4 | $0.8M | 10 | -23% | N/A |
#5 | $0.9M | 10 | 11% | N/A |